Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer.

MLA

Suenaga, Mitsukuni, et al. “Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer.” Cancers, vol. 16, no. 16, Aug. 2024, p. 2855. EBSCOhost, https://doi.org/10.3390/cancers16162855.

APA

Suenaga, M., Mashima, T., Kawata, N., Dan, S., Seimiya, H., & Yamaguchi, K. (2024). Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer. Cancers, 16(16), 2855. https://doi.org/10.3390/cancers16162855

Chicago

Suenaga, Mitsukuni, Tetsuo Mashima, Naomi Kawata, Shingo Dan, Hiroyuki Seimiya, and Kensei Yamaguchi. 2024. “Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer.” Cancers 16 (16): 2855. doi:10.3390/cancers16162855.